Given the known ability of IL-17 to maintain epithelial cell barrier function (64, 65), the authors conclude that riboflavin metabolite sensing MAIT cells regulate acute GVHD at least partially via IL-17A secretion. The gene discussed is IL17A; the disease is acute graft versus host disease.